Jacobs buys patent of BAYQIK sulphuric acid converter technology


Jacobs Engineering has acquired the patent rights for Bayer's BAYQIK quasi-isothermal sulphuric acid converter technology. 

Financial details of the deal have not yet been revealed by the companies.

Jacobs president petroleum and chemicals Gary Mandel said: “This acquisition is an exciting development for our Chemetics process technology solutions business and our process industry clients.

“BAYQIK is proven to be a superior and more flexible option for processing high-strength SO2 gas, a growing requirement for clients in the non-ferrous metallurgical acid plant market.

"BAYQIK is proven to be a superior and more flexible option for processing high-strength SO2 gas."

“We’re thrilled to add this robust technology to our sulphuric acid technology portfolio and offer this capability to clients by leveraging the global reach of Jacobs’ network.”

Under the agreement, Jacobs will gain access to the relevant Bayer’s technical, commercial and market information.

In addition, Bayer will be providing transitional services to ensure a seamless transfer of the BAYQIK business.

BAYQIK technology enables efficient conversion of process gas with high SO2 concentrations.

The technology was developed by Bayer and commercialised for more than a decade. A full-scale installation based on the technology has operated successfully for seven years.

Mandel further added that the acquisition complements Jacobs’s existing sulphuric acid technology portfolio, and supporting the company to provide state-of-the-art technology to both the low strength and high strength SO2 market segments.

Jacobs Engineering has been providing a full-spectrum technical, professional and construction services for industrial, commercial and government organisations globally. It has a workforce of more than 50,000 people and operates in more than 30 countries.